查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600975

吸入一氧化氮市场：按应用程式、最终用户划分 - 2025-2030 年全球预测

Inhaled Nitric Oxide Market by Application (Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease, Malaria Treatment), End-Users (Clinic, Hospital) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年吸入一氧化氮市场价值为7.7821亿美元，预计到2024年将达到8.2109亿美元，复合年增长率为5.83%，预计到2030年将达到11.5738亿美元。

吸入一氧化氮 (iNO) 是一种重要的治疗药物，用于治疗呼吸衰竭和肺动脉高压，主要用于新生儿和成人患者。 iNO 市场范围涵盖医疗保健环境中的各种应用，包括医院和专科诊所。 iNO 广泛用于新生儿肺血管舒张的治疗和某些心血管手术，扩大了最终用途的范围。市场成长受到输送系统技术进步的强烈影响，例如改善患者治疗效果和依从性的携带式设备。对非侵入性和微创治疗方案不断增长的需求进一步增强了市场潜力。最新的机会存在于新兴市场和开拓的人口统计中，需要策略性扩张和研发投资，以探索新的治疗适应症和配方。此外，与医疗机构的合作可以有助于采用和创新。然而，严格的监管要求以及与 iNO 疗法的开发和实施相关的高成本对市场成长构成了挑战。此外，来自替代疗法和非专利药的竞争可能会阻碍进展。儘管有这些限制，iNO 的创新途径包括改善递送机制、提高效率和扩大治疗适应症。将 iNO 与其他疗法结合以产生协同效应的研究也提供了另一种生长载体。市场的特征是竞争激烈、技术创新迅速。想要取得成功的公司应该专注于提高 iNO 治疗的有效性和安全性、简化监管核准以及扩大其地理和人口覆盖范围。透过解决这些方面，公司可以有效地占领并扩大其在不断增长的市场格局中的份额。

主要市场统计
基准年[2023] 77821万美元
预测年份 [2024] 82109万美元
预测年份 [2030] 115,738 万美元
复合年增长率（%） 5.83%

市场动态：快速发展的吸入一氧化氮市场的关键市场洞察

供需的动态交互作用正在改变吸入一氧化氮市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球呼吸系统疾病增加
    • 随着医疗保健支出的增加，新生儿加护治疗设施也随之增加
  • 市场限制因素
    • 吸入一氧化氮的治疗高成本
  • 市场机会
    • 改进吸入一氧化氮的生产和储存技术
    • 正在进行的研究以推进吸入一氧化氮的应用
  • 市场挑战
    • 政府对吸入一氧化氮的使用有严格的规定

波特五力：驾驭吸入一氧化氮市场的策略工具

波特的五力框架是了解吸入一氧化氮市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解吸入一氧化氮市场的外部影响

外部宏观环境因素在塑造吸入一氧化氮市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解吸入一氧化氮市场的竞争状况

吸入一氧化氮市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵吸入一氧化氮市场供应商绩效评估

FPNV 定位矩阵是评估吸入一氧化氮市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地呼吸系统疾病的发生率增加
      • 随着医疗费用的增加，新生儿加护治疗设施的增加
    • 抑制因素
      • 与吸入一氧化氮相关的治疗费用昂贵
    • 机会
      • 改进吸入一氧化氮的生产和储存技术
      • 持续研究推进吸入一氧化氮的应用
    • 任务
      • 关于吸入一氧化氮使用的严格政府法规
  • 市场区隔分析
    • 应用：慢性阻塞性肺病的发生率增加
    • 最终用户：医院新生儿和加加护病房越来越多地采用吸入一氧化氮装置
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章吸入一氧化氮市场：依应用分类

  • 急性呼吸频率综合症
  • 慢性阻塞性肺病
  • 疟疾治疗
  • 新生儿呼吸治疗
  • 结核病治疗

第七章 吸入一氧化氮市场：依最终使用者分类

  • 诊所
  • 医院

第八章美洲吸入一氧化氮市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太吸入一氧化氮市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲吸入一氧化氮市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Vero Biotech 获得 6,500 万美元的一氧化氮输送系统信贷额度
    • ThirdPol 对一氧化氮输送系统试验中的第一位患者进行了注射
    • Mallinckrodt 宣布 FDA 批准 INOmax EVOLVE DS 输送系统和 INOmax（一氧化氮）核准气瓶
    • 阿拉巴马大学研究人员接受津贴开发可以改善肺动脉高压患者生活品质的设备
    • Beyond Air 获得高达 4,000 万美元的债务融资
    • VERO Biotech 融资 3000 万美元，加速创新无槽输送系统的商业化
    • VERO Biotech 的第三代无罐吸入一氧化氮输送系统获得 FDA核准
    • SaNOtize 宣布获得 2,400 万美元 B 轮资金筹措，以推进一氧化氮治疗药物的开发，包括鼻喷剂，用于治疗和预防 COVID-19

公司名单

  • Air Liquide SA
  • Beyond Air, Inc.
  • GE HealthCare Technologies, Inc.
  • Getinge AB
  • Linde PLC
  • Mallinckrodt PLC
  • Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
  • Merck KGaA
  • NIOX Group PLC
  • Perma Pure LLC by Halma PLC
  • SOL Group
  • Third Pole, Inc.
  • VERO Biotech Inc.
Product Code: MRR-2D668742FD36

The Inhaled Nitric Oxide Market was valued at USD 778.21 million in 2023, expected to reach USD 821.09 million in 2024, and is projected to grow at a CAGR of 5.83%, to USD 1,157.38 million by 2030.

Inhaled Nitric Oxide (iNO) serves as a critical therapeutic agent primarily used for the treatment of respiratory failure and pulmonary hypertension in neonatal and adult patients. The scope of the iNO market encompasses a range of applications in healthcare settings, including hospitals and specialized clinics. The increasing incidence of chronic respiratory diseases and a growing preterm birth rate significantly drive the necessity for this therapeutic gas. iNO is extensively used to manage pulmonary vasodilation in neonates and certain cardiac surgeries, expanding its end-use scope. Market growth is strongly influenced by technological advancements in delivery systems, such as portable devices, which improve patient outcomes and compliance. The rising demand for non-invasive and minimally invasive therapeutic options further reinforces its market potential. Latest opportunities lie in emerging markets and untapped demographics, necessitating strategic expansion and investment in R&D to explore novel therapeutic indications and formulations. Additionally, partnerships with healthcare institutions can aid in widespread adoption and innovation. However, market growth faces challenges from stringent regulatory requirements and high costs associated with the development and delivery of iNO therapies. Furthermore, competition from alternative treatments and generic products can hinder advancements. Despite such limitations, innovation avenues in iNO include improving delivery mechanisms, increasing its efficiency, and expanding its therapeutic indications. Research into combining iNO with other therapeutic agents for synergistic effects offers another growth vector. The market is characterized by a blend of high competition and rapid innovation. Companies aiming for success should focus on enhancing the efficacy and safety of iNO treatments, streamline regulatory approvals, and expand their geographic and demographic reach. By addressing these aspects, businesses can effectively capture and expand their share in the growing inhaled nitric oxide market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 778.21 million
Estimated Year [2024] USD 821.09 million
Forecast Year [2030] USD 1,157.38 million
CAGR (%) 5.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhaled Nitric Oxide Market

The Inhaled Nitric Oxide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidents of respiratory disorders worldwide
    • Increase in neonatal intensive care facilities with growing healthcare expenditure
  • Market Restraints
    • High cost associated with treatments involving inhaled nitric oxide
  • Market Opportunities
    • Improvements in production and storage technologies of inhaled nitric oxide
    • Continuous research to boost the application of inhaled nitric oxide
  • Market Challenges
    • Stringent government regulations for inhaled nitric oxide usage

Porter's Five Forces: A Strategic Tool for Navigating the Inhaled Nitric Oxide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhaled Nitric Oxide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhaled Nitric Oxide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhaled Nitric Oxide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhaled Nitric Oxide Market

A detailed market share analysis in the Inhaled Nitric Oxide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhaled Nitric Oxide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhaled Nitric Oxide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Inhaled Nitric Oxide Market, highlighting leading vendors and their innovative profiles. These include Air Liquide SA, Beyond Air, Inc., GE HealthCare Technologies, Inc., Getinge AB, Linde PLC, Mallinckrodt PLC, Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation, Merck KGaA, NIOX Group PLC, Perma Pure LLC by Halma PLC, SOL Group, Third Pole, Inc., and VERO Biotech Inc..

Market Segmentation & Coverage

This research report categorizes the Inhaled Nitric Oxide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease, Malaria Treatment, Neonatal Respiratory Treatment, and Tuberculosis Treatment.
  • Based on End-Users, market is studied across Clinic and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidents of respiratory disorders worldwide
      • 5.1.1.2. Increase in neonatal intensive care facilities with growing healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with treatments involving inhaled nitric oxide
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in production and storage technologies of inhaled nitric oxide
      • 5.1.3.2. Continuous research to boost the application of inhaled nitric oxide
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for inhaled nitric oxide usage
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Application: Increasing incidences of chronic obstructive pulmonary disease
    • 5.2.2. End-Users: Growing deployment of inhaled nitric oxide devices in hospitals for neonatal and intensive care units
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Inhaled Nitric Oxide Market, by Application

  • 6.1. Introduction
  • 6.2. Acute Respiratory Distress Syndrome
  • 6.3. Chronic Obstructive Pulmonary Disease
  • 6.4. Malaria Treatment
  • 6.5. Neonatal Respiratory Treatment
  • 6.6. Tuberculosis Treatment

7. Inhaled Nitric Oxide Market, by End-Users

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Hospital

8. Americas Inhaled Nitric Oxide Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Inhaled Nitric Oxide Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Inhaled Nitric Oxide Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Vero Biotech Secures USD 65 Million Credit Facility for Nitric Oxide Delivery System
    • 11.3.2. Third Pole Doses First Patient in Trial with Nitric Oxide Delivery System
    • 11.3.3. Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax (Nitric Oxide) Mini-Cylinder
    • 11.3.4. UAB Researchers Receive Grant to Develop Devices That Can Improve Quality of Life for Patients with Pulmonary Hypertension
    • 11.3.5. Beyond Air Secures up to USD 40 Million Debt Financing
    • 11.3.6. VERO Biotech Raises USD 30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System
    • 11.3.7. VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System
    • 11.3.8. SaNOtize Announces USD 24 Million in Series B Funding to Advance It's Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Companies Mentioned

  • 1. Air Liquide SA
  • 2. Beyond Air, Inc.
  • 3. GE HealthCare Technologies, Inc.
  • 4. Getinge AB
  • 5. Linde PLC
  • 6. Mallinckrodt PLC
  • 7. Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
  • 8. Merck KGaA
  • 9. NIOX Group PLC
  • 10. Perma Pure LLC by Halma PLC
  • 11. SOL Group
  • 12. Third Pole, Inc.
  • 13. VERO Biotech Inc.

LIST OF FIGURES

  • FIGURE 1. INHALED NITRIC OXIDE MARKET RESEARCH PROCESS
  • FIGURE 2. INHALED NITRIC OXIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALED NITRIC OXIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INHALED NITRIC OXIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY MALARIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL RESPIRATORY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY TUBERCULOSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023